The abstract is read at the publisher; the summary is JClub's.
Plaque progression in atherosclerosis induces PPARα deficiency in NK cells, markedly diminishing mTOR signaling and weakening tumor immunosurveillance in both patients and atherosclerosis mouse models.
- Why it matters: Atherosclerosis is linked to higher and faster cancer development, but how plaque progression affects NK cell tumor surveillance and its molecular control is unclear.
- What they did: Peripheral NK cells from patients with early (<50% stenosis) versus advanced (≥50% stenosis) coronary lesions were profiled for PPARα and IFN-γ, while Apo-/- high-fat diet and aortic arch transplantation models tested NK cell checkpoint/effector function with or without oleoylethanolamide or MHY1485.
- The result: PPARα-deficient NK cells showed elevated immune checkpoint expression, an exhaustion phenotype, and reduced mTOR signaling; oleoylethanolamide restored NK effector function and improved tumor killing in vivo, with mTOR agonism partially rescuing the PPARα-loss defect.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.